GB9708976D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB9708976D0
GB9708976D0 GBGB9708976.7A GB9708976A GB9708976D0 GB 9708976 D0 GB9708976 D0 GB 9708976D0 GB 9708976 A GB9708976 A GB 9708976A GB 9708976 D0 GB9708976 D0 GB 9708976D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9708976.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB9708976.7A priority Critical patent/GB9708976D0/en
Publication of GB9708976D0 publication Critical patent/GB9708976D0/en
Priority to HU0003608A priority patent/HUP0003608A3/en
Priority to PL98336628A priority patent/PL336628A1/en
Priority to CA002288899A priority patent/CA2288899A1/en
Priority to JP54771298A priority patent/JP2002501506A/en
Priority to CN98806643A priority patent/CN1261350A/en
Priority to EP98924262A priority patent/EP0983244A1/en
Priority to AU76518/98A priority patent/AU725491B2/en
Priority to TR1999/02724T priority patent/TR199902724T2/en
Priority to KR19997010154A priority patent/KR20010012205A/en
Priority to PCT/EP1998/002583 priority patent/WO1998050364A1/en
Priority to IL13263198A priority patent/IL132631A0/en
Priority to BR9809591-9A priority patent/BR9809591A/en
Priority to CO98023497A priority patent/CO5050329A1/en
Priority to PE1998000326A priority patent/PE68799A1/en
Priority to MA25053A priority patent/MA26490A1/en
Priority to UY24986A priority patent/UY24986A1/en
Priority to ZA9803659A priority patent/ZA983659B/en
Priority to ARP980102028A priority patent/AR013078A1/en
Priority to NO995338A priority patent/NO995338D0/en
Priority to US09/656,379 priority patent/US6465485B1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GBGB9708976.7A 1997-05-03 1997-05-03 Compounds Pending GB9708976D0 (en)

Priority Applications (21)

Application Number Priority Date Filing Date Title
GBGB9708976.7A GB9708976D0 (en) 1997-05-03 1997-05-03 Compounds
PL98336628A PL336628A1 (en) 1997-05-03 1998-04-27 Derivatives of tetrahydroisoquinoline as modulators of d3 dopamine receptors
PCT/EP1998/002583 WO1998050364A1 (en) 1997-05-03 1998-04-27 Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
BR9809591-9A BR9809591A (en) 1997-05-03 1998-04-27 Tetraidoisoquinoline derivatives as modulators of dopamine d3 receptors
CA002288899A CA2288899A1 (en) 1997-05-03 1998-04-27 Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
JP54771298A JP2002501506A (en) 1997-05-03 1998-04-27 Dopamine D (3) Tetrahydroisoquinoline derivative as receptor modulator
CN98806643A CN1261350A (en) 1997-05-03 1998-04-27 Tetrahydroisoquinoline derivatives as modulators of dopamine D3 receptors
EP98924262A EP0983244A1 (en) 1997-05-03 1998-04-27 Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
AU76518/98A AU725491B2 (en) 1997-05-03 1998-04-27 Tetrahydroisoquinoline derivatives as modulators of dopamine D3 receptors
TR1999/02724T TR199902724T2 (en) 1997-05-03 1998-04-27 Tetrahydroisoquinoline derivatives as modulators of dopamine D3 receptors.
KR19997010154A KR20010012205A (en) 1997-05-03 1998-04-27 Tetrahydroisoquinoline Derivatives As Modulators Of Dopamine D3 Receptors
HU0003608A HUP0003608A3 (en) 1997-05-03 1998-04-27 Tetrahydroisoquinoline derivatives, process for producing them and pharmaceutical compositions containing them
IL13263198A IL132631A0 (en) 1997-05-03 1998-04-27 Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
CO98023497A CO5050329A1 (en) 1997-05-03 1998-04-29 NEW DERIVATIVES OF TETRAHYDROISOQUINOLEINE AND PROCEDURES FOR THEIR PREPARATION
PE1998000326A PE68799A1 (en) 1997-05-03 1998-04-29 TETRAHYDROISOKINOLINE DERIVATIVES AS DOPAMINE D3 RECEPTOR MODULATORS
MA25053A MA26490A1 (en) 1997-05-03 1998-04-30 NOVEL TETRAHYDROISOQUINOLEIN DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
UY24986A UY24986A1 (en) 1997-05-03 1998-04-30 COMPOUNDS
ZA9803659A ZA983659B (en) 1997-05-03 1998-04-30 Tetrahydroisoquinoline derivatives as modulators of Dopamine D3 Receptors.
ARP980102028A AR013078A1 (en) 1997-05-03 1998-04-30 DERIVATIVES OF TETRAHYDROISOKINOLEIN, A SALT OF THE SAME, PROCEDURE FOR ITS PREPARATION, PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS THEM AND THE USE OF THEM IN THE PREPARATION OF A MEDICINAL PRODUCT.
NO995338A NO995338D0 (en) 1997-05-03 1999-11-02 Tetrahydroisoquinoline derivatives as modulators of dopamine D3 receptors
US09/656,379 US6465485B1 (en) 1997-05-03 2000-09-06 Tetrahydroisoquinoline derivatives as modulators of dopamine D3 receptors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9708976.7A GB9708976D0 (en) 1997-05-03 1997-05-03 Compounds

Publications (1)

Publication Number Publication Date
GB9708976D0 true GB9708976D0 (en) 1997-06-25

Family

ID=10811734

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9708976.7A Pending GB9708976D0 (en) 1997-05-03 1997-05-03 Compounds

Country Status (4)

Country Link
KR (1) KR20010012205A (en)
CO (1) CO5050329A1 (en)
GB (1) GB9708976D0 (en)
ZA (1) ZA983659B (en)

Also Published As

Publication number Publication date
KR20010012205A (en) 2001-02-15
ZA983659B (en) 1999-11-01
CO5050329A1 (en) 2001-06-27

Similar Documents

Publication Publication Date Title
GB9714102D0 (en) Compounds
GB9715584D0 (en) Compounds
GB9710569D0 (en) Compounds
GB9708694D0 (en) Compounds
GB9708805D0 (en) Compounds
GB9709303D0 (en) Compounds
EP0999205A4 (en) Aminocycloalkane compounds
GB9711492D0 (en) Compounds
GB9704522D0 (en) Compounds
GB9712849D0 (en) Compounds
GB9702978D0 (en) Compounds
GB9706952D0 (en) Compounds
GB9708072D0 (en) Compounds
GB9704551D0 (en) Compounds
GB9704579D0 (en) Compounds
GB9704580D0 (en) Compounds
GB9704581D0 (en) Compounds
GB9704648D0 (en) Compounds
GB9704652D0 (en) Compounds
GB9705188D0 (en) Compounds
GB9705189D0 (en) Compounds
GB9705194D0 (en) Compounds
GB9705652D0 (en) Compounds
GB9706110D0 (en) Compounds
GB9708976D0 (en) Compounds